Literature DB >> 17120241

Outcome of retinoblastoma in east Africa.

R J C Bowman1, M Mafwiri, P Luthert, J Luande, M Wood.   

Abstract

We estimated the proportion of patients reaching a pediatric ophthalmology unit (Comprehensive Community Based Rehabilitation for Tanzania Disability Hospital, CCBRT) or an oncology unit (ORCI) in east Africa and investigated presentation, histology, and treatment outcomes of patients with retinoblastoma. A 5-year retrospective study identified 91 patients, representing approximately 18% of the nationwide total. Mean lag time was 10 months (standard deviation (SD) = 17) and mean follow-up was 8 months (SD = 11, range 0-40, n = 91). Thirty months disease-free survival probability was 0.23 (standard error = 0.07). Outcomes for retinoblastoma in Africa remain poor. The data presented here suggest strategies for improving the outcomes, including encouraging earlier presentation and establishment of multi-disciplinary treatment centers. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17120241     DOI: 10.1002/pbc.21080

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  30 in total

1.  5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene.

Authors:  Ru Liu; Xiao-Huan Zhang; Kun Zhang; Wei Li; Wen-Jun Wang; Di-Xian Luo; Ling Gao
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma.

Authors:  Shizheng Su; Jian Gao; Tao Wang; Ju Wang; Hong Li; Zhen Wang
Journal:  Tumour Biol       Date:  2015-04-19

3.  [Retinoblastoma in Malawi: why are admissions too late?].

Authors:  M Schulze Schwering; M Gandiwa; G Msukwa; M Spitzer; K Kalua; E M Molyneux
Journal:  Ophthalmologe       Date:  2014-12       Impact factor: 1.059

Review 4.  Current update on retinoblastoma.

Authors:  Samuel K Houston; Timothy G Murray; Stacey Quintero Wolfe; Cristina E Fernandes
Journal:  Int Ophthalmol Clin       Date:  2011

5.  Retinoblastoma: concerning its initiation and treatment.

Authors:  Chang Luo; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 6.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07

7.  [Retinoblastoma in Kenya: survival and prognostic factors].

Authors:  E N Gichigo; M M Kariuki-Wanyoike; K Kimani; M M Nentwich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

8.  Presentation of retinoblastoma at a paediatric eye clinic in ghana.

Authors:  V Essuman; C T Ntim-Amponsah; S Akafo; L Renner; L Edusei
Journal:  Ghana Med J       Date:  2010-03

9.  MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma.

Authors:  Zhenzhen Li; Jian Guo; Xiaolin Xu; Wenbin Wei; Junfang Xian
Journal:  Br J Radiol       Date:  2021-12-03       Impact factor: 3.039

10.  A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa.

Authors:  Saadiah Goolam; Hemant Kana; Nicky Welsh; Linda Wainwright; Janet Poole; Ismail Mayet
Journal:  Ocul Oncol Pathol       Date:  2017-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.